At JPM 2026 Bora Pharmaceuticals and EirGenix unveiled AI-driven manufacturing, US onshoring, continuous production and biosimilar partnerships reshaping Taiwan’s biopharma role.
Taiwan Biotech Leaders Embrace AI and Advanced Manufacturing at JPM 2026 Read More »
Insilico Medicine and Qilu Pharmaceutical launch an AI-driven collaboration worth up to $120M to discover small molecules for cardiometabolic diseases.
Insilico and Qilu Forge $120M AI Alliance to Target Cardiometabolic Disease Read More »
AI-driven drug discovery, lower rates and a looming patent cliff are set to accelerate biotech M&A in 2026. What investors and executives should watch.
AI Fuels Biotech M&A Boom in 2026 Read More »
Rebecca Simmons joins Qureight as COO to drive global growth of its AI CT imaging biomarkers and clinical data platform for lung and heart disease.
Qureight Appoints Rebecca Simmons as COO to Scale AI Imaging and Clinical Data Read More »
Servier and Insilico Medicine struck a multi-program AI oncology discovery collaboration worth up to $888M, including $32M upfront. A concise analysis of roles, strategy and realistic impact.
Servier and Insilico Sign $888M AI Oncology Discovery Deal Read More »
Insilico Medicine plans a $1 billion China hub for AI drug discovery. Analysis of why China appeals, how AI speeds discovery, and the global implications for biotech.
Insilico Medicine’s $1 Billion Bet on China: What It Means for AI Drug Discovery Read More »
Discover how AI and biotechnology together drive sustainable food production, unlock revenue in alternative proteins and precision fermentation, and optimize supply chains.
How AI and Biotech Are Powering New Growth in the Food Industry Read More »
UKRI funds three doctoral training centres integrating AI and engineering biology to train PhD cohorts in biocatalysis, protein engineering and microbial bioengineering.
UK Funds AI-Driven Doctoral Centres to Build Next-Gen Biotechnology Skillset Read More »
Novartis commits to a $1.7B collaboration with Relation Therapeutics to use AI and multi-omic patient data for faster target discovery in atopic dermatology.
Novartis and Relation: AI-Powered Target Discovery for Immuno-Dermatology Read More »
How AI-led start-ups are accelerating drug discovery, precision medicine, and hospital workflows. Practical signals for founders and investors.
AI & Biotech: How Start-ups Are Rewriting Health Innovation Read More »
